Artemis Bioservices

Artemis Bioservices is a private, CRO specialized in vaccine and antiviral evaluation. In addition, Artemis provides services in the area of monoclonal antibodies characterization and evaluation of toxicity. Vision of Artemis Bioservices: The vision of Artemis Bioservices is to become a strategic partner in the process of antiviral, antibody and vaccine development against emerging viral diseases. Mission of Artemis Bioservices: To assist biotech and biopharmaceutical companies to accelerate the development and licensing of safe and effective antiviral intervention strategies, in particular against emerging, zoonotic and arboviral diseases, by offering customized in-vitro testing and in-vivo immunogenicity and efficacy testing capabilities Artemis Bioservices provides high quality preclinical and clinical services to developers of antiviral intervention strategies who want to evaluate the immunogenicity and efficacy of candidate products, especially against emerging, vector-borne and zoonotic viruses. Artemis Bioservices has recently been certified GLP compliant. Artemis Bioservices is located in the Yes!Delft Labs building, at Molengraaffsingel 10, 2629 JD, Delft, The Netherlands.